Addressing Unmet Medical Needs in NeuroPsychiatry Through Precision Neuroscience

Our Mission

ReST develops breakthrough therapies to treat complex neurological and psychiatric disorders.  Our lead program, RST-01 is focused on treatment for Post Traumatic Stress Disorder (PTSD)

Our Team

Patrick Tricoli, PharmD, MBA

Patrick Tricoli, PharmD, MBA

Chief Executive Officer

Gilles Rubinstenn, PhD, MBA

Gilles Rubinstenn, PhD, MBA

Chairman of the Board & Chief Innovation Officer

Reina Benabou, MD, PhD

Reina Benabou, MD, PhD

Chief Medical Officer

Anthony Franco, J.D.

Anthony Franco, J.D.

Chief Operating Officer

Our Partners